(Q43808736)

27 November 2017

Outpatient parenteral antimicrobial therapy (OPAT) for the treatment of osteomyelitis: evaluation of efficacy, tolerance and cost (English)

1 reference

27 November 2017

1 reference

Bernard L

1

1 reference

27 November 2017

El-Hajj

2

1 reference

27 November 2017

Pron B

3

1 reference

27 November 2017

Lotthé A

4

1 reference

27 November 2017

Gleizes V

5

1 reference

27 November 2017

Signoret F

6

1 reference

27 November 2017

Denormandie P

7

1 reference

27 November 2017

Gaillard JL

8

1 reference

27 November 2017

Perronne C

9

1 reference

27 November 2017

1 December 2001

1 reference

Journal of Clinical Pharmacy and Therapeutics

27 November 2017

1 reference

27 November 2017

26

1 reference

27 November 2017

6

1 reference

27 November 2017

445-451

1 reference

Medicare coverage of outpatient ambulatory intravenous antibiotic therapy: a program that pays for itself.

27 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2001.00380.X

Continuous infusion of beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2001.00380.X

Efficacy of continuous infusion of ceftazidime for patients with neutropenic fever after high-dose chemotherapy and peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2001.00380.X

Drug therapy. Serum bactericidal activity as a monitor of antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2001.00380.X

Oral ciprofloxacin compared with parenteral antibiotics in the treatment of osteomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2001.00380.X

Adverse effects of outpatient parenteral antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2001.00380.X

Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2001.00380.X

Pharmacodynamics of ceftazidime administered as continuous infusion or intermittent bolus alone and in combination with single daily-dose amikacin against Pseudomonas aeruginosa in an in vitro infection model

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2001.00380.X

Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2001.00380.X

Influence of four modes of administration on penetration of aztreonam, cefuroxime, and ampicillin into interstitial fluid and fibrin clots and on in vivo efficacy against Haemophilus influenzae

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2001.00380.X

Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2001.00380.X

Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2001.00380.X

Continuous infusion of ceftazidime in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2001.00380.X

Treatment of gram-negative bacillary septicemia with cefoperazone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2001.00380.X

Is continuous infusion of beta-lactam antibiotics worthwhile?--efficacy and pharmacokinetic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2001.00380.X

21 January 2018

Serum bactericidal test

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2001.00380.X

Place of parenteral cephalosporins in the ambulatory setting: clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2001.00380.X

Pharmacoeconomic considerations in the ambulatory use of parenteral cephalosporins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2001.00380.X

Parenteral cephalosporin therapy in ambulatory care: advantages and disadvantages

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2001.00380.X

10.1046/J.1365-2710.2001.00380.X

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference